TherapeuticsMD
TXMD
$1.86
Share price
-0.53%
Change (1 day)
-47.31%
Change (1 year)
Categories
TherapeuticsMD (TXMD) - Total liabilities
Total liabilities on the balance sheet as of September 2023 : $22.44 M
According to TherapeuticsMD's latest financial reports the company's total liabilities are $22.44 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
TherapeuticsMD - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $55.31 M | -78.98% |
| 2021-12-31 | $0.26 B | -13.91% |
| 2020-12-31 | $0.30 B | 19.01% |
| 2019-12-31 | $0.25 B | 124.34% |
| 2018-12-31 | $0.11 B | 759.23% |
| 2017-12-31 | $13.32 M | -11.09% |
| 2016-12-31 | $14.98 M | 40.47% |
| 2015-12-31 | $10.66 M | -0.23% |
| 2014-12-31 | $10.69 M | 46.08% |
| 2013-12-31 | $7.31 M | -0.56% |
| 2012-12-31 | $7.35 M | 133.58% |
| 2011-12-31 | $3.15 M | 1253.1% |
| 2010-12-31 | $0.23 M | -79.94% |
| 2009-12-31 | $1.16 M | 3149.59% |
| 2008-12-31 | $0.03 M | -54.1% |
| 2007-12-31 | $0.07 M | -56.72% |
| 2006-12-31 | $0.17 M | -63.54% |
| 2005-12-31 | $0.49 M | 1228.79% |
| 2004-12-31 | $0.03 M | 15.59% |
| 2003-12-31 | $0.03 M | 91.08% |
| 2002-12-31 | $0.01 M | -27.06% |
| 2001-12-31 | $0.02 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $137.21 B | 611,338.88% | 🇺🇸 USA |
 AbbVie ABBV | $124.31 B | 553,859.27% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | $23.3 M | 3.83% | 🇺🇸 USA |
 Royalty Pharma RPRX | $6.29 B | 27,962.74% | 🇬🇧 UK |
 Lannett Company LCI | $0.74 B | 3,228.21% | 🇺🇸 USA |